Haptoglobin binds apolipoprotein e and influences cholesterol esterification in the cerebrospinal Fluid

Journal of Neurochemistry

Volumn 110, Issue 1, 2009, Pages 255-263

  Salvatore, Alfonso ^a   Cigliano, Luisa ^a   Carlucci, Alessandro ^a   Bucci, Enrico M ^b   Abrescia, Paolo ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b Bioindustry Park del Canavese   (Italy)

Author keywords

Apolipoprotein A I; Apolipoprotein E; Cholesterol; Haptoglobin; Lecithin cholesterol acyltransferase; Oxidative stress

Indexed keywords

ALBUMIN; APOLIPOPROTEIN A1; APOLIPOPROTEIN E; CHOLESTEROL; CHOLESTEROL ESTER; HAPTOGLOBIN; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE;

ARTICLE; BINDING SITE; CEREBROSPINAL FLUID; CHOLESTEROL ESTERIFICATION; ENZYME ACTIVITY; HUMAN; LIPID ANALYSIS; LIPID OXIDATION; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; PROTEIN LIPID INTERACTION;

APOLIPOPROTEIN A-I; APOLIPOPROTEINS E; BINDING SITES; BRAIN; BRAIN CHEMISTRY; CEREBROSPINAL FLUID; CHOLESTEROL; ESTERIFICATION; HAPTOGLOBINS; HUMANS; IMMUNOBLOTTING; MULTIPLE SCLEROSIS; NERVE DEGENERATION; NEUROCHEMISTRY; PROTEIN BINDING;

EID: 67449124352     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2009.06121.x     Document Type: Article

References (49)

1. Adibhatla R. M. Hatcher J. F. (2008) Altered lipid metabolism in brain injury and disorders. Subcell. Biochem. 49, 241 268.
2. Albers J. J., Marcovnia S. M. Christenson R. H. (1992) Lecithin-cholesterol acyltransferase in human cerebrospinal fluid: reduced level in patients with multiple sclerosis and evidence for a direct synthesis in the brain. Int. J. Clin. Lab. Res. 22, 169 172.
3. Balestrieri M., Cigliano L., De Simone M. L. et al. (2001) Haptoglobin inhibits lecithin-cholesterol acyltransferase in human ovarian follicular fluid. Mol. Reprod. Dev. 59, 186 191. (Pubitemid 32391244)
4. Björkhem I. (2002) Do oxysterols control cholesterol homeostasis? J. Clin. Invest. 110, 725 730. (Pubitemid 35050945)
5. Björkhem I., Lütjohann D., Breuer O. et al. (1997) Importance of a novel oxidative mechanism for elimination of brain cholesterol. Turnover of cholesterol and 24(S)-hydroxycholesterol in rat brain as measured with 18O2 techniques in vivo and in vitro. J. Biol. Chem. 272, 30178 30184. (Pubitemid 27512218)
6. Chamoun V., Zeman A., Blennow K. et al. (2001) Haptoglobins as markers of blood-CSF barrier dysfunction: the findings in normal CSF. J. Neurol. Sci. 182, 117 121. (Pubitemid 33786707)
7. Chan W., Fornwald J., Brawner M. et al. (1996) Native complex formation between apolipoprotein E isoforms and the Alzheimer's disease peptide A beta. Biochemistry 35, 7123 7130. (Pubitemid 26182103)
8. Cigliano L., Spagnuolo M. S., Dale B. et al. (2001) Estradiol esterification in the human preovulatory follicle. Steroids 66, 889 896. (Pubitemid 33064431)
9. Cigliano L., Spagnuolo M. S. Abrescia P. (2003) Quantitative variations of the isoforms in haptoglobin 1-2 and 2-2 individual phenotypes. Arch. Biochem. Biophys. 416, 227 237. (Pubitemid 36945161)
10. Curtiss L. K., Valenta D. T., Hime N. J. et al. (2006) What is so special about apolipoprotein AI in reverse cholesterol transport? Arterioscler Thromb. Vasc. Biol. 26, 12 19. (Pubitemid 43732223)
11. Demeester N., Castro G., Desrumaux C. et al. (2000) Characterization and functional studies of lipoproteins, lipid transfer proteins, and lecithin:cholesterol acyltransferase in CSF of normal individuals and patients with Alzheimer's disease. J. Lip. Res. 41, 963 974. (Pubitemid 30434328)
12. Donahue J. E. Johanson C. E. (2008) Apolipoprotein E, amyloid-beta, and blood-brain barrier permeability in Alzheimer disease. J. Neuropathol. Exp. Neurol. 67, 261 270.
13. Eckersall P. D. Conner J. G. (1990) Plasma haptoglobin in cattle (Bos taurus) exists as polymers in association with albumin. Comp. Biochem. Physiol. 96B, 309 314. (Pubitemid 20174158)
14. Fassbender K., Simons M., Bergmann C. et al. (2001) Simvastatin strongly reduces levels of Alzheimer's disease beta-amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo. Proc. Natl Acad. Sci. USA 98, 5371 5373.
15. Gaillard O., Gervais A., Meillet D. et al. (1998) Apolipoprotein E and multiple sclerosis : a biochemical and genetic investigation. J. Neurol. Sci. 158, 180 186. (Pubitemid 28342082)
16. Greenow K., Pearce N. J Ramji D. P. (2005) The key role of apolipoprotein E in atherosclerosis. J. Mol. Med. 83, 329 342. (Pubitemid 41201798)
17. Gunzburg M. J., Perugini M. A., Howlett G. J. et al. (2007) Structural basis for the recognition and cross-linking of amyloid fibrils by human apolipoprotein E. J. Biol. Chem. 282, 35831 35841. (Pubitemid 350277107)
18. Halliwell B. Gutteridge J. M. C (1999 Free Radicals in Biology and Medicine. Oxford University Press, New York T. L., Friedlander E. J., Rall Jr S. C. et al. (1983) The receptor-binding domain of human apolipoprotein E. Binding of apolipoprotein E fragments. J. Biol. Chem. 258, 12341 12347.
19. Jick H, Zornberg G. L., Jick S. S. et al. (2000) Statins and the risk of dementia. Lancet 356, 1627 1631. (Pubitemid 30835686)
20. Kalmovarin N., Friedrichs W. E., O'Brien H. et al. (1991) Extrahepatic expression of plasma protein genes during inflammation. Inflammation 15, 369 379.
21. Kölsch H., Lütjohann D., Tulke A. et al. (1999) The neurotoxic effect of 24-hydroxycholesterol on SH-SY5Y human neuroblastoma cells. Brain Res. 818, 171 175. (Pubitemid 29227299)
22. Koudinov A. R. Koudinova N.V. (2005) Cholesterol homeostasis failure as a unifying cause of synaptic degeneration. J. Neurol. Sci. 15, 229 230.
23. Langlois M. R. Delanghe J. R. (1996) Biological and clinical significance of haptoglobin polymorphism in humans. Clin. Chem. 42, 1589 1600. (Pubitemid 26354735)
24. Lee M. Y., Kim S. Y., Choi J. S. et al. (2002) Upregulation of haptoglobin in reactive astrocytes after transient forebrain ischemia in rats. J. Cereb. Blood Flow Metab. 22, 1176 1180.
25. Lütjohann D., Breuer O., Ahlborg G. et al. (1996) Cholesterol homeostasis in human brain: evidence for an age-dependent flux of 24S-hydroxycholesterol from the brain into the circulation. Proc. Natl. Acad. Sci. 93, 9799 9804. (Pubitemid 26296689)
26. Pitas R. E., Boyles J. K., Lee S. H. et al. (1987) Astrocytes synthesize apolipoprotein E and metabolize apolipoprotein E-containing lipoproteins. Biochim. Biophys. Acta 917, 148 161. (Pubitemid 17231059)
27. Porta A., Cassano E., Balestrieri M. et al. (1999) Haptoglobin transport into human ovarian follicles and its binding to apolipoprotein A-1. Zygote 7, 67 77. (Pubitemid 129639335)
28. Puglielli L., Tanzi R. E. Kovacs D.M. (2003) Alzheimer's disease: the cholesterol connection. Nat. Neurosci. 6, 345 351. (Pubitemid 36373979)
29. Rahman S. M. A., Van Dam A. M., Schultzberg M. et al. (2005) High cholesterol diet results in increased expression of interleukin-6 and caspase-1 in the brain of apolipoprotein E knockout and wild type mice. J. Neuroimmunol. 169, 59 67. (Pubitemid 41527092)
30. Rebeck G.W., LaDu M.J., Estus S. et al. (2006) The generation and function of soluble apoE receptors in the CNS. Mol. Neurodegener. 1, 1 15.
31. Sadowski M., Pankiewicz J., Scholtzova H. et al. (2004) A synthetic peptide blocking the apolipoprotein E/beta-amyloid binding mitigates beta-amyloid toxicity and fibril formation in vitro and reduces beta-amyloid plaques in transgenic mice. Am. J. Pathol. 165, 937 948. (Pubitemid 39129300)
32. Sadrzadeh S. M Bozorgmehr J. (2004) Haptoglobin phenotypes in health and disorders. Am. J. Clin. Pathol. 121 Suppl S : 97 104.
33. Salvatore A., Cigliano L., Bucci E. M. et al. (2007) Haptoglobin binding to apolipoprotein A-I prevents damage from hydroxyl radicals on its stimulatory activity of the enzyme lecithin-cholesterol acyl-transferase. Biochemistry 46, 11158 11168. (Pubitemid 47502782)
34. Sanchez D. J., Armstrong L., Aguilar R. et al. (2001) Haptoglobin gene expression in human glioblastoma cell lines. Neurosci. Lett. 303, 181 184. (Pubitemid 32373285)
35. Schagger H Von Jagow G. (1987) Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal. Biochem. 166, 368 379. (Pubitemid 18004907)
36. Simons M., Keller P., De Strooper B. et al. (1998) Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons. Proc. Natl. Acad. Sci. USA 95, 6460 6464. (Pubitemid 28249035)
37. Smeets M. B., Sluijter J. P., Donners M. M. et al. (2003) Increased arterial expression of a glycosylated haptoglobin isoform after balloon dilation. Cardiovasc. Res. 58, 689 695. (Pubitemid 36694455)
38. Spagnuolo M. S., Cigliano L. Abrescia P. (2003) The binding of haptoglobin to apolipoprotein A-I: influence of hemoglobin and cancanavalin. A. Biol. Chem. 384, 1593 1596. (Pubitemid 38054882)
39. Spagnuolo M. S., Cigliano L., D'Andrea L. D. et al. (2005) Assignment of the binding site for haptoglobin on apolipoprotein A-I. J. Biol. Chem. 280, 1193 1198.
40. Swanberg M., Duvefelt K., Diez M. et al. (2006) Genetically determined susceptibility to neurodegeneration is associated with expression of inflammatory genes. Neurobiol. Dis. 24, 67 88. (Pubitemid 44437610)
41. Szedlacsek S. E., Wasowicz E., Hulea S. A. et al. (1995) Esterification of oxysterols by human plasma lecithin-cholesterol acyltransferase. J. Biol. Chem. 270, 11812 11819.
42. Temel R. E., Trigatti B., DeMattos R. B. et al. (1997) Scavenger receptor class B, type I (SR-BI) is the major route for the delivery of high density lipoprotein cholesterol to the steroidogenic pathway in cultured mouse adrenocortical cells. Proc. Natl. Acad. Sci. 94, 13600 13605. (Pubitemid 28009629)
43. Vance J. E., Hayashi H. Karten B. (2005) Cholesterol homeostasis in neurons and glial cells. Semin. Cell Dev. Biol. 16, 193 212. (Pubitemid 40432121)
44. Vega G. L. Weiner M. F. (2007) Plasma 24S hydroxycholesterol response to statins in Alzheimer's disease patients: effects of gender, CYP46, and ApoE polymorphisms. J. Mol. Neurosci. 33, 51 55. (Pubitemid 47574958)
45. Vollmer T., Key L., Durkalski V. et al. (2004) Oral simvastatin treatment in relapsing-remitting multiple sclerosis. Lancet 363, 1607 1608. (Pubitemid 38625664)
46. Wassel J. (2000) Haptoglobin function and polymorphism. Clin. Lab. 46, 547 552.
47. Wolozin B., Kellman W., Ruosseau P. et al. (2000) Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors. Arch. Neurol. 57, 1439 1443. (Pubitemid 30769120)
48. Xu S., Laccotripe M., Huang X. et al. (1997) Apolipoproteins of HDL can directly mediate binding to the scavenger receptor SR-BI, an HDL receptor that mediates selective lipid uptake. J. Lipid Res. 38, 1289 1298. (Pubitemid 27332557)
49. Yerbury J. J., Rybchyn M. S., Easterbrook-Smith S. B. et al. (2005) The acute phase protein haptoglobin is a mammalian extracellular chaperone with an action similar to clusterin. Biochemistry 44, 10914 10925. (Pubitemid 41153652)